Financials
- Market Capitalization 6.4 B
- Employee 258
- Founded 2014
- CEO N/A
- Website www.cogentbio.com
- Headquarter Delaware, United States
- FIGI BBG007DHZQR7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1156 | SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD | ||
| 1186 | LQDA Liquidia Corporation - Common Stock | 71.21 USD | -8.62% | -10.15% | -0.03% | +215.09% | 6.33 B USD | ||
| 1198 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 309.25 USD | -2.21% | -2.80% | +21.27% | +65.27% | 6.20 B USD |
Frequently asked questions about Cogent Biosciences, Inc. - Common Stock
What is the Cogent Biosciences, Inc. - Common Stock stock price today?
The current price of Cogent Biosciences, Inc. - Common Stock (COGT) is 37.46. Over the past 24 hours, the stock has changed by -3.63%. Follow the COGT chart for real-time price dynamics.
What is the stock ticker of Cogent Biosciences, Inc. - Common Stock?
Cogent Biosciences, Inc. - Common Stock trades under the ticker COGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cogent Biosciences, Inc. - Common Stock stock going up?
COGT has changed by -6.12% over the last week, +12.16% over the last month, and +139.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cogent Biosciences, Inc. - Common Stock net income for the last quarter?
Cogent Biosciences, Inc. - Common Stock reported net income of -97.35 M for the last quarter. The previous quarter showed -102.49 M, which means net income changed by +5.02%.
How many employees does Cogent Biosciences, Inc. - Common Stock have?
As of the latest available data, Cogent Biosciences, Inc. - Common Stock has 258 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cogent Biosciences, Inc. - Common Stock EBITDA?
Cogent Biosciences, Inc. - Common Stock EBITDA is -104.64 M, and its EBITDA margin is 77.51 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cogent Biosciences, Inc. - Common Stock stock?
You can buy Cogent Biosciences, Inc. - Common Stock (COGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cogent Biosciences, Inc. - Common Stock stock?
Investing in Cogent Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COGT chart and related analysis on metatrader.com as part of your research.